Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: LEO Laboratories Limited, Horizon, Honey Lane, Hurley, Maidenhead, Berkshire, SL6 6RJ, UK
Fucidin is indicated in the treatment of all staphylococcal infections due to susceptible organisms such as: osteomyelitis, pneumonia, septicaemia, wound infections, endocarditis, superinfected cystic fibrosis, cutaneous infections.
Fucidin should be administered intravenously whenever oral therapy is inappropriate, which includes cases where absorption from the gastro-intestinal tract is unpredictable.
Each 5 ml of Fucidin Suspension is therapeutically equivalent to 175 mg of sodium fusidate owing to its lower oral bioavailability. Therefore the following dosages are recommended:
Adults: 15 ml three times daily.
Children:
0-1 year: 1 ml/kg bodyweight daily, divided into 3 equal doses.
1-5 years: 5 ml 3 times daily.
5-12 years: 10 ml 3 times daily.
Elderly: No dosage alterations are necessary in the elderly.
Since Fucidin is excreted in the bile, no dosage modifications are needed in renal impairment.
The dosage in patients undergoing haemodialysis needs no adjustment as Fucidin is not significantly dialysed.
For oral administration. The Suspension should be shaken well before use and dilution is not recommended.
Acute symptoms of overdose include gastrointestinal disturbances. Management should be directed towards alleviation of symptoms. Dialysis will not increase the clearance of fusidic acid.
An overdose of 4 g/day for a duration of ten days in an adult has been reported without any adverse events.
An overdose of 1,250 mg/day for a duration of seven days in a child (three years old) has been reported without any adverse events.
Shelf life: 3 years.
This medicinal product does not require any special storage conditions.
Bottles of 50 ml.
No special requirements for disposal.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
